IQVIA: A Positive Long-Term Outlook Despite Trump Legislation

I rate IQVIA (NYSE: IQV ) with a buy rating. I am of the opinion that the company will generate value for its investors despite the U.S. President, Donald Trump, signing an executive order mandating drugmakers toDaniel Mellado is an economist from Carabobo University with a Master's Degree in Statistics from Simon Bolivar University, both obtained in Venezuela.Daniel worked analyzing the agricultural commodity market and the financial investment portfolio for an agribusiness group. Then, he managed two team ...